Indranil Sen, CFO, Biocon resigned
Sen spent a decade with Biocon and held various key roles,
Sen spent a decade with Biocon and held various key roles,
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
The investment will catalyse various components of the IndiaAI Mission
The validations confirm the completion of the applications and commence the scientific review process
Acquisition of exclusive commercialization rights for European markets
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Subscribe To Our Newsletter & Stay Updated